Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors

Endocrine Pathology

Volumn 18, Issue 4, 2007, Pages 223-232

  Stilling, Gail A ^a   Zhang, Heyu ^a   Ruebel, Katharina H ^a   Leontovich, Alexey A ^a   Jin, Long ^a   Tanizaki, Yoshinori ^a   Zhang, Shuya ^a   Erickson, Lori A ^a   Hobday, Timothy ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinoids; EGFR receptor; TGF receptors; Vitamin D3 receptor

Indexed keywords

CHROMOGRANIN B; GEFITINIB; OCTREOTIDE; TRANSFORMING GROWTH FACTOR BETA1; VITAMIN D RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; ILEUM TUMOR; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CARCINOMA; RECTUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOVIRIDAE; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOID TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENETIC VECTORS; HUMANS; ILEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; OCTREOTIDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CALCITRIOL; RECEPTORS, SOMATOSTATIN; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTORS;

EID: 40749151511     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-007-9001-3     Document Type: Article

References (37)

1. Oberg K. Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment. Curr Opin Oncol 14:38-45, 2002.
2. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 128:1717-51, 2005.
3. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 89:151-60, 2005.
4. Evers BM, Townsend CM Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, et al. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101:303-11, 1991.
5. Pfranger R, Wirnsberger G, Niederle B, Behmel A, Rinner I, Mandl A, et al. Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-1): characterization and effects of a 5-azacytidine on proliferation. Int J Oncol 8:513-20, 1996.
6. Takahashi Y, Onda M, Tanaka N, Seya T. Establishment and characterization of two new rectal neuroendocrine cell carcinoma cell lines. Digestion 62:262-70, 2000.
7. Ahlund L, Nilsson O, Kling-Petersen T, Wigander A, Theodorsson E, Dahlstrom A, et al. Serotonin-producing carcinoid tumour cells in long-term culture. Studies on serotonin release and morphological features. Acta Oncol 28:341-6, 1989.
8. Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC. The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 91:2340-8, 2006.
9. Galli G, Zonefrati R, Gozzini A, Mavilia C, Martineti V, Tognarini I, et al. Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma. Endocr Relat Cancer 13:79-93, 2006.
10. Kolby L, Wangberg B, Ahlman H, Tisell LE, Fjalling M, Forssell-Aronsson E, et al. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors. World J Surg 22:679-83, 1998.
11. Kolby L, Bernhardt P, Ahlman H, Wangberg B, Johanson V, Wigander A, et al. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. Am J Pathol 158:745-55, 2001.
12. Kolby L, Bernhardt P, Johanson V, Schmitt A, Ahlman H, Forssell-Aronsson E, et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. Br J Cancer 93:1144-51, 2005.
13. Anthony LB, Martin W, Delbeke D, Sandler M. Somatostatin receptor imaging: predictive and prognostic considerations. Digestion 57 Suppl 1:50-3, 1996.
14. Janson ET, Gobl A, Kalkner KM, Oberg K. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. Cancer Res 56:2561-5, 1996.
15. Hopfner M, Sutter AP, Gerst B, Zeitz M, Scherubl H. A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839). Br J Cancer 89:1766-75, 2003.
16. Nilsson O, Wangberg B, McRae A, Dahlstrom A, Ahlman H. Growth factors and carcinoid tumours. Acta Oncol 32:115-24, 1993.
17. Oberg K. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann N Y Acad Sci 733:46-55, 2005.
18. Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, et al. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod Path 18:1329-35, 2005.
19. Grotzinger C. Tumour biology of gastroenteropancreatic neuroendocrine tumours. Neuroendocrinology 80 Suppl 1:8-11, 2004.
20. Yao JC, Zhang JX, Rashid A, Yeung SC, Szklaruk J, Hess K, et al. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res 13:234-40, 2007.
21. Chaudhry A, Papanicolaou V, Oberg K, Heldin CH, Funa K. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res 52:1006-12, 1992.
22. Jin L, Kulig EJ, Qian X, Scheithauer BW, Eberhardt NL, Lloyd RV. A human pituitary adenoma cell line proliferates and maintains some differentiated functions following expression of Sv40 large T-antigen. Endocr Pathol 9:169-84, 1998.
23. Van Doren K, Gluzman Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol Cell Biol 4:1653-6, 1984.
24. Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, et al. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocrine 29:435-44, 2006.
25. Ruebel KH, Jin L, Qian X, Scheithauer BW, Kovacs K, Nakamura N, et al. Effects of DNA methylation on galectin-3 expression in pituitary tumors. Cancer Res 65:1136-40, 2005.
26. Moghal N, Sternberg PW. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr Opin Cell Biol 11:190-6, 1999.
27. Janmaat ML, Kruyt FAE, Rodriguez JA, Giaccone G. Inhibition of the epidermal growth factor receptor induces apoptosis in A431 cells but not in non-small-cell lung cancer cell lines. Proc Am Assoc Cancer Res 43:A3901, 2002.
28. Hobday TJ, Mahoney M, Erlichman C, Lloyd R, Kim G, Mulkerin D, et al. Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET); a phase II consortium (P2C) study (Abstract 4083). J Clin Oncol 23 16S part 1:328s, 2005.
29. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 348:1134-49, 2003.
30. Feldman SA, Eiden LE. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr Pathol 14:3-23, 2003.
31. Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106:499-509, 2001.
32. Huh YH, Jeon SH, Yoo SH. Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J Biol Chem 278:40581-9, 2003.
33. Stilling GA, Bayliss JM, Jin L, Zhang H, Lloyd RV. Chromogranin A transcription and gene expression in Folliculostellate (TtT/GF) cells inhibit cell growth. Endocr Pathol 16:173-86, 2005.
34. Inomoto C, Umemura S, Egashira N, Minematsu T, Takekoshi S, Itoh Y, et al. Granulogenesis in non-neuroendocrine COS-7 cell induced by EGFP-tagged chromogranin a gene transfection: identical and distinct distribution of CgA and EGFP. J Histochem Cytochem 55:487-93, 2007.
35. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T. Metastatic growth of lung cancer cells is extremely reduced in Vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 89-90:545-7, 2004.
36. Guzey M, Luo J, Getzenberg RH. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells. J Cell Biochem 93:271-85, 2004.
37. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, et al. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356-65, 2007.